HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Christos Emmanouilides Selected Research

ibritumomab tiuxetan (Zevalin)

10/2009Review of Y-ibritumomab tiuxetan as first-line consolidation radio-immunotherapy for B-cell follicular non-Hodgkin's lymphoma.
11/2007Radioimmunotherapy for non-hodgkin lymphoma : historical perspective and current status.
10/2007Safety and efficacy of yttrium-90 ibritumomab tiuxetan in older patients with non-Hodgkin's lymphoma.
9/2007Treatment-related myelodysplastic syndrome and acute myelogenous leukemia in patients treated with ibritumomab tiuxetan radioimmunotherapy.
9/2007Weight-based dosing of Yttrium 90 ibritumomab tiuxetan in patients with relapsed or refractory B-cell non-Hodgkin lymphoma.
5/2007Long-term responses in patients with recurring or refractory B-cell non-Hodgkin lymphoma treated with yttrium 90 ibritumomab tiuxetan.
4/2006Treatment with yttrium 90 ibritumomab tiuxetan at early relapse is safe and effective in patients with previously treated B-cell non-Hodgkin's lymphoma.
12/2004Antilymphoma treatments given subsequent to Yttrium 90 ibritumomab tiuxetan are feasible in patients with progressive non-Hodgkin's lymphoma: a review of the literature.
9/2004Yttrium 90-labeled ibritumomab tiuxetan radioimmunotherapy produces high response rates and durable remissions in patients with previously treated B-cell lymphoma.
6/2004Durable responses after ibritumomab tiuxetan radioimmunotherapy for CD20+ B-cell lymphoma: long-term follow-up of a phase 1/2 study.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Christos Emmanouilides Research Topics

Disease

24Non-Hodgkin Lymphoma (Lymphosarcoma)
10/2009 - 02/2002
14Lymphoma (Lymphomas)
10/2009 - 09/2002
13Neoplasms (Cancer)
08/2015 - 05/2002
6Waldenstrom Macroglobulinemia (Macroglobulinemia)
04/2009 - 05/2001
6B-Cell Lymphoma (Lymphoma, B Cell)
11/2007 - 09/2002
4Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
09/2007 - 04/2003
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
12/2019 - 07/2008
3Colorectal Neoplasms (Colorectal Cancer)
11/2008 - 05/2007
3Hodgkin Disease (Hodgkin's Disease)
01/2004 - 08/2003
2Breast Neoplasms (Breast Cancer)
01/2022 - 08/2016
2Lung Neoplasms (Lung Cancer)
08/2015 - 03/2015
2Renal Cell Carcinoma (Grawitz Tumor)
06/2015 - 06/2009
2Neoplasm Metastasis (Metastasis)
06/2009 - 07/2008
2B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
11/2008 - 04/2003
2Hematologic Neoplasms (Hematological Malignancy)
07/2007 - 01/2006
2Stomatitis
11/2006 - 12/2004
2Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
01/2006 - 07/2005
1Brain Neoplasms (Brain Tumor)
08/2016
1Ischemia
08/2015
1Thrombosis (Thrombus)
08/2015
1Pulmonary Embolism
06/2015
1Venous Thrombosis (Deep-Vein Thrombosis)
06/2015
1Neutropenia
01/2010
1Myelodysplastic Syndromes (Myelodysplastic Syndrome)
09/2007
1Chromosome Aberrations (Chromosome Abnormalities)
09/2007
1Graft vs Host Disease (Graft-Versus-Host Disease)
06/2006
1Cytomegalovirus Infections (Inclusion Disease)
06/2006
1Multiple Myeloma
01/2006
1Lymphoproliferative Disorders (Lymphoproliferative Disorder)
01/2006
1Hairy Cell Leukemia
01/2006
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
01/2006
1Cytopenia
07/2005
1Anemia
07/2005

Drug/Important Bio-Agent (IBA)

15ibritumomab tiuxetan (Zevalin)FDA Link
10/2009 - 02/2002
14Rituximab (Mabthera)FDA Link
04/2009 - 05/2002
7YttriumIBA
09/2007 - 02/2002
6Bevacizumab (Avastin)FDA Link
01/2022 - 05/2007
6Monoclonal AntibodiesIBA
05/2007 - 04/2003
3GemcitabineFDA Link
08/2016 - 12/2002
3Yttrium-90IBA
10/2007 - 04/2003
3Pharmaceutical PreparationsIBA
04/2004 - 12/2002
2Taxoids (Taxanes)IBA
01/2022 - 08/2016
2Vinorelbine (Navelbine)FDA LinkGeneric
08/2016 - 12/2002
2Pemetrexed (MTA)FDA Link
08/2016 - 01/2010
2InterferonsIBA
06/2015 - 01/2006
2Oxaliplatin (Eloxatin)FDA LinkGeneric
11/2008 - 05/2007
2Fibroblast Growth Factor 7FDA Link
11/2006 - 12/2004
2CD20 AntigensIBA
04/2006 - 04/2003
2Biological ProductsIBA
07/2005 - 05/2002
2Glucose (Dextrose)FDA LinkGeneric
01/2004 - 07/2003
2Paclitaxel (Taxol)FDA LinkGeneric
11/2003 - 12/2002
2Proteins (Proteins, Gene)FDA Link
04/2003 - 04/2003
2Immunoglobulin M (IgM)IBA
04/2003 - 04/2003
1Sorafenib (BAY 43-9006)FDA Link
08/2016
1Anastrozole (Arimidex)FDA LinkGeneric
08/2016
1ixabepilone (BMS 247550)FDA Link
08/2016
1Capecitabine (Xeloda)FDA Link
08/2016
1Alprostadil (Muse)FDA LinkGeneric
08/2015
1Heparin (Liquaemin)FDA LinkGeneric
08/2015
1Tyrosine Kinase InhibitorsIBA
06/2015
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
06/2015
1EverolimusFDA Link
06/2015
1Folic Acid (Vitamin M)FDA LinkGeneric
01/2010
1OsseusIBA
06/2009
1fludarabineIBA
04/2009
1epratuzumabIBA
11/2008
1SodiumIBA
11/2008
1ProMune (CpG 7909)IBA
10/2007
1Toll-Like Receptor 9IBA
10/2007
1Alkylating AgentsIBA
09/2007
1Purine NucleosidesIBA
09/2007
1Leucovorin (Folinic Acid)FDA Link
05/2007
1Fluorouracil (Carac)FDA LinkGeneric
05/2007
1Interleukin-2 (IL2)IBA
12/2006
1ValganciclovirFDA Link
06/2006
1Ganciclovir (Cytovene)FDA LinkGeneric
06/2006
1Gemtuzumab (Mylotarg)FDA Link
01/2006
1Thalidomide (Thalomid)FDA Link
01/2006
1CalicheamicinsIBA
01/2006
1Alemtuzumab (Campath)FDA Link
01/2006
1Angiogenesis InhibitorsIBA
01/2006
1Bortezomib (Velcade)FDA Link
01/2006
1Proteasome InhibitorsIBA
01/2006

Therapy/Procedure

14Radioimmunotherapy
10/2009 - 02/2002
12Therapeutics
01/2022 - 08/2002
8Drug Therapy (Chemotherapy)
01/2022 - 12/2002
4Aftercare (After-Treatment)
09/2007 - 04/2003
3Immunotherapy
10/2009 - 05/2001
3Stem Cell Transplantation
04/2006 - 09/2002
2Radiotherapy
08/2016 - 12/2004
2Replantation
08/2015 - 03/2015
2Transplantation
08/2015 - 12/2004
2Pneumonectomy (Lung Volume Reduction)
03/2015 - 07/2008
2Hematopoietic Stem Cell Transplantation
11/2006 - 12/2004
1Cardiopulmonary Bypass (Heart-Lung Bypass)
12/2019
1Orthopedic Procedures
06/2015
1Induction Chemotherapy
10/2009
1Radiofrequency Ablation
06/2009
1Adrenalectomy
07/2008
1Autologous Transplantation
04/2006